Tempus Labs - Bathi resik saben saham (EPS TTM) TEM

The annual volatility of TTM net income per share for Tempus AI, Inc (TEM) reflects market expectations, where the value 10.50 represents the latest figure. This trend is supported by oncologists' confidence in precise data analytics and a formidable AI barrier to entry for new players. Growth is driven by the company's ownership of a global library of molecular data, which distinguishes Tempus AI, Inc (TEM) from other precision medicine developers.

This indicator measures the percentage change in net earnings per share over a rolling twelve-month period, reflecting the business's scaling pace. The metric allows investors to assess yield sustainability and earnings volatility during shifts in market phases. For Tempus AI, Inc (TEM), under the leadership of Eric Lefkofsky, this figure confirms the effective monetization of AI algorithms in genomics. By analyzing the rolling year-over-year EPS growth trend, one can determine a safe entry point into the asset.